Sodium Hydroxide → Bupivacaine (USAN:INN:BAN)

HRID 2220784

반응식

HRID 2220784 반응식
[CH3:1][CH2:2][CH2:3][CH2:4][N:5]1[CH:10]([C:11]([NH:13][C:14]2[C:15]([CH3:21])=[CH:16][CH:17]=[CH:18][C:19]=2[CH3:20])=[O:12])[CH2:9][CH2:8][CH2:7][CH2:6]1.Cl.[OH-].[Na+]>O>[CH3:1][CH2:2][CH2:3][CH2:4][N:5]1[CH:10]([C:11]([NH:13][C:14]2[C:15]([CH3:21])=[CH:16][CH:17]=[CH:18][C:19]=2[CH3:20])=[O:12])[CH2:9][CH2:8][CH2:7][CH2:6]1

참가 물질

4

반응물 2

HCID 14798Sodium HydroxideHCID 64737Bupivacaine Hydrochloride

생성물 1

HCID 2474Bupivacaine (USAN:INN:BAN)

시약·촉매·용매 1

HCID 962Water용매

실험 절차

Bupivacaine hydrochloride (Sigma-Aldrich Corporation, St. Louis, Mo.) was dissolved in deionized (DI) water at a concentration of 40 mg/ml (saturation). A calculated amount of sodium hydroxide (in the form of 1 N solution) was added to the solution and the pH of the final mixture was adjusted to 10 to precipitate the Bupivacaine base. The precipitated product was filtered, and further washed with DI water at least three times. The precipitated product was dried at ca. 40° C. in vacuum for 24 hours.

후처리

  1. customto precipitate the Bupivacaine base
  2. filtrationThe precipitated product was filtered
  3. washfurther washed with DI water at least three times
  4. customThe precipitated product was dried at ca. 40° C. in vacuum for 24 hours

출처 및 근거

ORD 기록
ord-8f98ef1c64c147ff95d61b55905fc186
출처 데이터셋
uspto-grants-2008_05
특허 번호
US07368126B2

연결된 노트

불러오는 중…